OR WAIT null SECS
September 03, 2023
Excipients should be treated equally when it comes to quality management, risk assessment, and testing.
Coprocessed excipients save time and cost while improving performance in a widening array of dosage forms.
August 01, 2023
In this episode, David Tisi and Reenal Gandhi provide expert insights into advances and innovations changing the drug dosage form landscape.
April 15, 2023
Lipids aren’t the only important ingredients influencing stability and in vivo performance.
April 03, 2023
Impurities and batch-to-batch variability present the biggest challenges.
March 03, 2023
February 21, 2023
In this episode, Ana Ladino provides an update on the acceptance of a novel excipient onto CDER’s pilot program.
November 03, 2022
High-concentration injectable formulations present unique challenges.
November 01, 2022
FDA has accepted Ashland’s Viatel bioresorbable mPEG-PDLLA pharmaceutical excipient into the FDA Novel Excipient Review Pilot Program.
October 31, 2022
Roquette has launched excipients PEARLITOL CR-H and PEARLITOL 200 GT.